A new consensus from the National Psoriasis Foundation outlines a clear benchmark for remission to improve treatment decisions and patient outcomes.

Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new presentation of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), in a ...

Two patients present with pink plaques on different parts of their head and face. Can you correctly identify each case?

Local broadcasting celebrity Graham Liver from BBC Radio Lancashire, will unveil two commemorative plaques donated to The ...

Celltrion announces US FDA approval of additional presentation of Steqeyma, expanding dosing options for paediatric patients: Incheon, South Korea Tuesday, June 17, 2025, 16:00 Hr ...

A fallen firefighter from the Inland Northwest will be honored alongside other fallen firefighters from around Washington in ...

People in communities talk about living in what are called Sacrifice Zones - where the land meets industry in Canada.

The Washington State Fire Service is inviting the community to attend the Washington State Fallen Firefighter’s Memorial ...

Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new presentation of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), in a ...

The UPMC Pinnacle Foundation will invest in a $5,000 annual scholarship for the West York Police Department to send a student ...